Regulatory News: GeNeuro (Euronext Paris : CH0308403085 – GNRO), société biopharmaceutique développant de nouveaux traitements pour les maladies neurodégénératives et auto-immunes, annonce que le...
Regulatory News: GeNeuro (Euronext Paris : CH0308403085 - GNRO), société biopharmaceutique dont l'objectif est de s'attaquer aux facteurs de progression des maladies neurodégénératives et...
Regulatory News: GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing new treatments for neurodegenerative and autoimmune diseases, announces that the Geneva...
Regulatory News: GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company focused on addressing the factors driving the progression of neurodegenerative and autoimmune...
Regulatory News: GeNeuro (Euronext Paris : CH0308403085 – GNRO), société biopharmaceutique développant de nouveaux traitements pour les maladies neurodégénératives et auto-immunes, telles que la...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0075 | 4.80769230769 | 0.156 | 0.242 | 0.143 | 1211418 | 0.18370378 | DE |
4 | 0.0813 | 98.9051094891 | 0.0822 | 0.28 | 0.0674 | 694254 | 0.1615845 | DE |
12 | 0.0855 | 109.615384615 | 0.078 | 0.28 | 0.0428 | 429555 | 0.14098451 | DE |
26 | 0.0935 | 133.571428571 | 0.07 | 0.28 | 0.0428 | 206475 | 0.1355147 | DE |
52 | -1.0965 | -87.0238095238 | 1.26 | 2.35 | 0.0428 | 129411 | 0.18707625 | DE |
156 | -3.5165 | -95.5570652174 | 3.68 | 4.01 | 0.0428 | 46471 | 0.31874276 | DE |
260 | -3.0365 | -94.890625 | 3.2 | 6.28 | 0.0428 | 31499 | 0.65525301 | DE |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관